OPEN Foundation.png
Europe’s Leading Psychedelic Conference Returns to Amsterdam
26 mai 2022 09h00 HE | OPEN Foundation
AMSTERDAM, May 26, 2022 (GLOBE NEWSWIRE) -- The OPEN Foundation, a European non-profit organisation dedicated to advancing psychedelic research and the responsible integration of psychedelics into...
Baanbrekende Europese psychedelische conferentie vindt weer plaats in Amsterdam
26 mai 2022 09h00 HE | OPEN Foundation
AMSTERDAM, May 26, 2022 (GLOBE NEWSWIRE) -- De OPEN Foundation, een Europese non-profitorganisatie die zich sinds 2007 richt op het bevorderen van psychedelisch onderzoek en verantwoorde integratie...
IRWIN NATURALS LOGO [NEW BRANDING].jpg
Klee Irwin Presenting at Psychedelic Capital
25 mai 2022 11h49 HE | Irwin Naturals
LOS ANGELES, May 25, 2022 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced today that Klee Irwin, CEO, will be presenting at the...
87520785_101152591495741_6497961433500745728_o.jpg
Mycotopia Therapies Inc. Update on Ei.Ventures and Strategic Investments
09 mai 2022 08h30 HE | Mycotopia Therapies Inc.
MIAMI, May 09, 2022 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC Pink: TPIA), a biopharma company focused on research, technology, and the development of medical psychedelics, and Ei.Ventures...
87520785_101152591495741_6497961433500745728_o.jpg
Mycotopia Therapies Inc. To Enter $13 Billion Medicinal Mushroom Market With HAVN Life Sciences' Biopharmaceuticals And Ei.Ventures MANA Products
21 mars 2022 08h30 HE | Mycotopia Therapies Inc.
MIAMI, March 21, 2022 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC Pink: TPIA) (the “Company”), a biopharma company focused on research, technology, and the development of medical psychedelics,...
President and Co-Founder of the Schultes Center for Amazonian Ethnobotanical Research Joins Luminous Mind Inc. Scientific Advisor Network
10 mars 2022 13h00 HE | Luminous Mind Inc.
BOSTON, March 10, 2022 (GLOBE NEWSWIRE) -- Luminous Mind Inc. today announced the appointment of ethnobotanist, Michael J. Maki to its Scientific Advisory Network to assist in searching for...
CBThera-Logo-for-White-BG-no-box-2500px.png
Two esteemed doctors join CB Therapeutics in its exploration of innovative approaches to the production of novel psychedelics and cannabinoids so researchers can address the unmet needs of patient communities
20 déc. 2021 08h08 HE | CB Therapeutics
SAN DIEGO, Dec. 20, 2021 (GLOBE NEWSWIRE) -- CB Therapeutics today announces the appointments of Dr. Stephen Wright and Dr. Brian Barnett to its newly formed Medical Advisory Board. Dr. Wright...
CB Therapeutics and atai Life Sciences launch TryptageniX to sustainably supply and develop clinically relevant compounds to tackle the growing mental health crisis
09 déc. 2021 13h11 HE | CB Therapeutics
SAN DIEGO, Dec. 09, 2021 (GLOBE NEWSWIRE) -- CB Therapeutics, a biosynthesis company focused on creating ethical and environmentally-friendly products to improve mental health and increase...
Logo (1)
U.S.-Based Psychedelic Healthcare VC Fund, Palo Santo, Appoints New Members to Its Advisory Board, Amid Rapid Growth in Psychedelic Sector
08 nov. 2021 08h37 HE | Palo Santo
CHICAGO, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Palo Santo, the leading U.S.–based psychedelic investment fund, announced its advisory board, which includes some of the world’s foremost leaders in their...
Picture1.jpg
Clearmind Medicine Appoints Distinguished Addiction Experts Professor Wim van den Brink and Professor Gabriele Fischer to Its Scientific Advisory Board
14 oct. 2021 08h00 HE | Clearmind Medicine
TORONTO, Ontario, Oct. 14, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Clearmind Medicine Inc. (CSE: CMND) (FSE: CWY0) (“Clearmind” or the "Company"), a psychedelic medicine biotech company focused...